In this second of two podcasts, hear Dr Robin Dore discuss key information from ACR Convergence 2021, including the use of COVID-19 vaccine in immunosuppressed adults with autoimmune diseases; the cardiovascular risk of hydroxychloroquine in rheumatoid arthritis; whether the boxed warning for romosozumab helps prevent inappropriate use in postmenopausal women with osteoporosis and a history of myocardial infarction or stroke; how the incidence of cardiovascular events in patients with rheumatoid arthritis compares with that of patients with diabetes; and evaluating the risk of mortality in patients with suboptimally treated gout. This activity is available for CE/CME credit. Claim your credit at pce.is/ACR.